25.91 USD
+1.81 (+7.51%)
25.9 USD
-0.01 (-0.04%)
Taking everything into account, SMTI scores 3 out of 10 in our fundamental rating. SMTI was compared to 187 industry peers in the Health Care Equipment & Supplies industry. SMTI may be in some trouble as it scores bad on both profitability and health. SMTI has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
SMTI had negative earnings in the past year.
SMTI had a positive operating cash flow in the past year.
SMTI had negative earnings in each of the past 5 years.
In the past 5 years SMTI always reported negative operating cash flow.
1.2 Ratios
SMTI's Return On Assets of -52.74% is on the low side compared to the rest of the industry. SMTI is outperformed by 67.91% of its industry peers.
SMTI has a Return On Equity of -609.72%. This is amonst the worse of the industry: SMTI underperforms 82.89% of its industry peers.
SMTI has a Return On Invested Capital of 2.18%. This is in the better half of the industry: SMTI outperforms 68.98% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -52.74% | ||
| ROE | -609.72% | ||
| ROIC | 2.18% |
ROA(3y)-9.93%
ROA(5y)-19.18%
ROE(3y)-17.7%
ROE(5y)-29.97%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Operating Margin value of 1.46%, SMTI is doing good in the industry, outperforming 66.31% of the companies in the same industry.
SMTI has a better Gross Margin (92.25%) than 97.86% of its industry peers.
In the last couple of years the Gross Margin of SMTI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.46% | ||
| PM (TTM) | N/A | ||
| GM | 92.25% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.07%
GM growth 5Y0.2%
2. Health
2.1 Basic Checks
SMTI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, SMTI has more shares outstanding
SMTI has more shares outstanding than it did 5 years ago.
SMTI has a worse debt/assets ratio than last year.
2.2 Solvency
SMTI has an Altman-Z score of 2.28. This is not the best score and indicates that SMTI is in the grey zone with still only limited risk for bankruptcy at the moment.
SMTI's Altman-Z score of 2.28 is fine compared to the rest of the industry. SMTI outperforms 64.17% of its industry peers.
A Debt/Equity ratio of 7.33 is on the high side and indicates that SMTI has dependencies on debt financing.
SMTI has a Debt to Equity ratio of 7.33. This is amonst the worse of the industry: SMTI underperforms 86.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 7.33 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.28 |
ROIC/WACC0.25
WACC8.57%
2.3 Liquidity
A Current Ratio of 1.80 indicates that SMTI should not have too much problems paying its short term obligations.
SMTI has a Current ratio of 1.80. This is in the lower half of the industry: SMTI underperforms 67.38% of its industry peers.
SMTI has a Quick Ratio of 1.60. This is a normal value and indicates that SMTI is financially healthy and should not expect problems in meeting its short term obligations.
SMTI has a Quick ratio (1.60) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.8 | ||
| Quick Ratio | 1.6 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 26.06% over the past year.
Looking at the last year, SMTI shows a very strong growth in Revenue. The Revenue has grown by 30.55%.
The Revenue has been growing by 49.08% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)26.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%126.47%
Revenue 1Y (TTM)30.55%
Revenue growth 3Y53.13%
Revenue growth 5Y49.08%
Sales Q2Q%21.51%
3.2 Future
The Earnings Per Share is expected to grow by 60.78% on average over the next years. This is a very strong growth
Based on estimates for the next years, SMTI will show a quite strong growth in Revenue. The Revenue will grow by 15.94% on average per year.
EPS Next Y117%
EPS Next 2Y76.21%
EPS Next 3Y60.78%
EPS Next 5YN/A
Revenue Next Year19.89%
Revenue Next 2Y18.28%
Revenue Next 3Y15.94%
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for SMTI. In the last year negative earnings were reported.
SMTI is valuated rather expensively with a Price/Forward Earnings ratio of 20.57.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SMTI indicates a rather cheap valuation: SMTI is cheaper than 82.35% of the companies listed in the same industry.
SMTI's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.78.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 20.57 |
4.2 Price Multiples
SMTI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SMTI is cheaper than 68.98% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 38.53 |
4.3 Compensation for Growth
SMTI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SMTI's earnings are expected to grow with 60.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y76.21%
EPS Next 3Y60.78%
5. Dividend
5.1 Amount
SMTI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
25.91
+1.81 (+7.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners12.93%
Inst Owner Change1.65%
Ins Owners8.75%
Ins Owner Change-0.04%
Market Cap231.64M
Revenue(TTM)101.90M
Net Income(TTM)-37.49M
Analysts82.5
Price Target41.82 (61.4%)
Short Float %7.19%
Short Ratio5.54
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)94.9%
Min EPS beat(2)48.75%
Max EPS beat(2)141.04%
EPS beat(4)3
Avg EPS beat(4)39.09%
Min EPS beat(4)-53.45%
Max EPS beat(4)141.04%
EPS beat(8)5
Avg EPS beat(8)-0.7%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.17%
Min Revenue beat(2)-3.03%
Max Revenue beat(2)0.69%
Revenue beat(4)1
Avg Revenue beat(4)-1.13%
Min Revenue beat(4)-3.03%
Max Revenue beat(4)0.69%
Revenue beat(8)4
Avg Revenue beat(8)0.62%
Revenue beat(12)5
Avg Revenue beat(12)-2.06%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-18%
PT rev (3m)-18%
EPS NQ rev (1m)370.83%
EPS NQ rev (3m)370.83%
EPS NY rev (1m)119.39%
EPS NY rev (3m)119.39%
Revenue NQ rev (1m)-7.03%
Revenue NQ rev (3m)-7.03%
Revenue NY rev (1m)-2.33%
Revenue NY rev (3m)-2.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 20.57 | ||
| P/S | 2.27 | ||
| P/FCF | N/A | ||
| P/OCF | 61.31 | ||
| P/B | 37.67 | ||
| P/tB | N/A | ||
| EV/EBITDA | 38.53 |
EPS(TTM)-0.73
EYN/A
EPS(NY)1.26
Fwd EY4.86%
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)0.42
OCFY1.63%
SpS11.4
BVpS0.69
TBVpS-2.08
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -52.74% | ||
| ROE | -609.72% | ||
| ROCE | 2.76% | ||
| ROIC | 2.18% | ||
| ROICexc | 3.02% | ||
| ROICexgc | 8.32% | ||
| OM | 1.46% | ||
| PM (TTM) | N/A | ||
| GM | 92.25% | ||
| FCFM | N/A |
ROA(3y)-9.93%
ROA(5y)-19.18%
ROE(3y)-17.7%
ROE(5y)-29.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.07%
GM growth 5Y0.2%
F-Score4
Asset Turnover1.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 7.33 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 7.07 | ||
| Cap/Depr | 95.41% | ||
| Cap/Sales | 4.58% | ||
| Interest Coverage | 0.49 | ||
| Cash Conversion | 59.26% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.8 | ||
| Quick Ratio | 1.6 | ||
| Altman-Z | 2.28 |
F-Score4
WACC8.57%
ROIC/WACC0.25
Cap/Depr(3y)14.51%
Cap/Depr(5y)146.81%
Cap/Sales(3y)0.77%
Cap/Sales(5y)3.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%126.47%
EPS Next Y117%
EPS Next 2Y76.21%
EPS Next 3Y60.78%
EPS Next 5YN/A
Revenue 1Y (TTM)30.55%
Revenue growth 3Y53.13%
Revenue growth 5Y49.08%
Sales Q2Q%21.51%
Revenue Next Year19.89%
Revenue Next 2Y18.28%
Revenue Next 3Y15.94%
Revenue Next 5YN/A
EBIT growth 1Y131.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y73.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y224.27%
OCF growth 3YN/A
OCF growth 5YN/A
SANARA MEDTECH INC / SMTI FAQ
What is the ChartMill fundamental rating of SANARA MEDTECH INC (SMTI) stock?
ChartMill assigns a fundamental rating of 3 / 10 to SMTI.
What is the valuation status for SMTI stock?
ChartMill assigns a valuation rating of 4 / 10 to SANARA MEDTECH INC (SMTI). This can be considered as Fairly Valued.
How profitable is SANARA MEDTECH INC (SMTI) stock?
SANARA MEDTECH INC (SMTI) has a profitability rating of 2 / 10.
How financially healthy is SANARA MEDTECH INC?
The financial health rating of SANARA MEDTECH INC (SMTI) is 2 / 10.
What is the expected EPS growth for SANARA MEDTECH INC (SMTI) stock?
The Earnings per Share (EPS) of SANARA MEDTECH INC (SMTI) is expected to grow by 117% in the next year.